Beach Medical X1 Llc

CLIA Laboratory Citation Details

1
Total Citation
3
Total Deficiencyies
3
Unique D-Tags
CMS Certification Number 10D2332934
Address 401 N Mills Ave Ste A, Orlando, FL, 32803
City Orlando
State FL
Zip Code32803
Phone407 502-0073
Lab DirectorRYAN NAUGHTIN

Citation History (1 survey)

Survey - April 27, 2026

Survey Type: Standard

Survey Event ID: N2MG11

Deficiency Tags: D0000 D5413 D5445

Summary:

Summary Statement of Deficiencies D0000 An announced CLIA initial survey was conducted at Beach Medical X1 LLC on April 27, 2026. The laboratory was surveyed under 42 CFR Part 493 CLIA requirements. Standard deficiencies cited are as follows: D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) (b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (b)(1) Water quality. (b)(2) Temperature. (b)(3) Humidity. (b)(4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on record review and interview, the laboratory failed to document the refrigerator, and the room temperature and humidity from 12/04/2025 to 04/13/2026. Findings included: 1. Review of the Daily Environmental & QC (Quality Control) Log noted, "Take refrigerator and room temperature readings along with relative humidity readings daily." 2. Review of the laboratory's QC documents revealed, the refrigerator, and the room temperature and humidity were not recorded. 3. During an interview on 04/27/2026 at 11:05 AM, the Laboratory Director acknowledged the refrigerator, and the room temperature and humidity were not recorded. D5445 CONTROL PROCEDURES CFR(s): 493.1256(d)(1)(2)(g) (d) Unless CMS Approves a procedure, specified in Appendix C of the State Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- (d)(1) Perform control procedures as defined in this section unless otherwise specified in the additional specialty and subspecialty requirements at 493. 1261 through 493.1278. (d)(2) For each test system, perform control procedures using the number and frequency specified by the manufacturer or established by the laboratory when they meet or exceed the requirements in paragraph (d)(3) of this section. (d)(3) At least once each day patient specimens are assayed or examined perform the following for: This STANDARD is not met as evidenced by: Based on record review and interview, the laboratory failed to run daily Quality Controls (QC) on the day of testing for two (Patient #3 and #4) of four (Patient #1 - #4) patients tested from 12/04/2025 to 04/13/2026. Findings included: 1. Review of the procedure titled, Using this Log noted, QC should be run daily and "Run QC before testing patients." 2. Review of the procedure titled, Individualized Quality Control Plan(IQCP) noted, "CLIA (Clinical Laboratory Improvements Amendments) requires a minimum QC frequency of two levels of controls each day of patient testing." 3. Review of the QC instrument printout revealed there were no instrument printouts documenting the controls were run on 04/13/2026. 4. Review of the patient reports for 04/13/2026 revealed, two patient testosterone results were reported out. 5. During an interview on 04/27/2026 at 11:05, the Laboratory Director acknowledged the calibration was performed on 04/13/2026, but did not see any documentation of the daily QC being run. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access